Bianca Santomasso
Overview
Explore the profile of Bianca Santomasso including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
2318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thompson J, Schneider B, Brahmer J, Zaid M, Achufusi A, Armand P, et al.
J Natl Compr Canc Netw
. 2024 Nov;
22(9):582-592.
PMID: 39536465
The NCCN Guidelines for the Management of Immunotherapy-Related Toxicities are intended to provide oncology practitioners with guidance on how to manage the wide-ranging and potentially fatal toxicities that may occur...
2.
Park J, Nath K, Devlin S, Sauter C, Palomba M, Shah G, et al.
Nat Med
. 2023 Jul;
29(7):1710-1717.
PMID: 37400640
In preclinical models, anakinra, an IL-1 receptor antagonist (IL-1Ra), reduced immune effector cell-associated neurotoxicity syndrome (ICANS) without compromising anti-CD19 chimeric antigen receptor (CAR) T-cell efficacy. We initiated a phase 2...
3.
Thompson J, Schneider B, Brahmer J, Achufusi A, Armand P, Berkenstock M, et al.
J Natl Compr Canc Netw
. 2022 Apr;
20(4):387-405.
PMID: 35390769
The aim of the NCCN Guidelines for Management of Immunotherapy-Related Toxicities is to provide guidance on the management of immune-related adverse events resulting from cancer immunotherapy. The NCCN Management of...
4.
Santomasso B, Ghosh M, Schneider B, Bollin K
J Clin Oncol
. 2022 Mar;
40(13):1509.
PMID: 35245095
No abstract available.
5.
Pennisi M, Sanchez-Escamilla M, Flynn J, Shouval R, Tomas A, Silverberg M, et al.
Blood Adv
. 2021 Aug;
5(17):3397-3406.
PMID: 34432870
Patients who develop chimeric antigen receptor (CAR) T-cell-related severe cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS) exhibit hemodynamic instability and endothelial activation. The EASIX (Endothelial Activation...
6.
Garcia-Recio M, Wudhikarn K, Pennisi M, Alonso-Trillo R, Flynn J, Shouval R, et al.
Transplant Cell Ther
. 2021 Mar;
27(3):233-240.
PMID: 33781518
CD19-targeted chimeric antigen receptor (CAR) T cells have shown excellent activity against relapsed and refractory (R/R) diffuse large B cell lymphoma (DLBCL). CAR T cell therapy is associated with early...
7.
Remsik J, Wilcox J, Babady N, McMillen T, Vachha B, Halpern N, et al.
Cancer Cell
. 2021 Jan;
39(2):276-283.e3.
PMID: 33508216
SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction that emerges weeks after the acute respiratory infection. To better understand this pathology, we prospectively analyzed of a cohort of cancer...
8.
Remsik J, Wilcox J, Babady N, McMillen T, Vachha B, Halpern N, et al.
medRxiv
. 2020 Sep;
PMID: 32995805
SARS-CoV-2 infection induces a wide spectrum of neurologic dysfunction. Here we show that a particularly vulnerable population with neurologic manifestations of COVID-19 harbor an influx of inflammatory cytokines within the...
9.
Yang T, Wijetunga N, Yamada J, Wolden S, Mehallow M, Goldman D, et al.
Neuro Oncol
. 2020 Jun;
23(1):134-143.
PMID: 32592583
Background: Leptomeningeal metastases (LM) are associated with limited survival and treatment options. While involved-field radiotherapy is effective for local palliation, it lacks durability. We evaluated the toxicities of proton craniospinal...
10.
Thompson J, Schneider B, Brahmer J, Andrews S, Armand P, Bhatia S, et al.
J Natl Compr Canc Netw
. 2020 Mar;
18(3):230-241.
PMID: 32135517
The NCCN Guidelines for Management of Immunotherapy-Related Toxicities provide interdisciplinary guidance on the management of immune-related adverse events (irAEs) resulting from cancer immunotherapy. These NCCN Guidelines Insights describe symptoms that...